| Deal Information |
|
||||
| Credit & Investment Research |
|
||||
| Market Research |
|
||||
| News |
|
||||
|
Alkermes acquired all the outstanding capital stock of Enzytech in exchange for #.# mil common shares valued at $##.## mil. Shareholders received .#### share per each common share held, #.## shares for each share of convertible preferred…
|
|